BioLineRx Ltd.
BLRX
$2.55
-$0.04-1.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.39M | 1.40M | 1.18M | 12.74M | 17.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.39M | 1.40M | 1.18M | 12.74M | 17.25M |
| Cost of Revenue | 278.00K | 291.00K | 230.00K | 6.28M | 7.02M |
| Gross Profit | 1.11M | 1.11M | 950.00K | 6.46M | 10.23M |
| SG&A Expenses | 3.67M | 3.01M | 3.14M | 8.99M | 15.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.56M | 12.30M | 11.47M | 22.81M | 30.50M |
| Operating Income | -12.17M | -10.90M | -10.29M | -10.07M | -13.25M |
| Income Before Tax | -10.14M | -9.74M | -2.03M | -2.98M | -7.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.14 | -9.74 | -2.03 | -2.98 | -7.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.15M | 1.84M | 851.00K | -- | -- |
| Net Income | -6.99M | -7.90M | -1.18M | -2.98M | -7.82M |
| EBIT | -12.17M | -10.90M | -10.29M | -10.07M | -13.25M |
| EBITDA | -11.83M | -10.46M | -9.77M | -7.83M | -10.29M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 10.59B | 10.30B | 9.86B | 8.50B | 7.09B |
| Average Diluted Shares Outstanding | 10.59B | 10.30B | 9.86B | 8.50B | 7.09B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |